Corporate
Apr. 12, 2011
Abbott Customers Get $52 Million
A class of drug retailers and wholesalers who sued Abbott Laboratories over a price increase for an HIV drug will receive $52 million under the terms of a settlement filed with the court Friday.
Daily Journal Staff Writer
SAN FRANCISCO - Every lawyer knows litigation is a little like gambling, and in a recent month-long antitrust trial against pharmaceutical company Abbott Laboratories, three of the four sets of plaintiffs suing the company over its price increase for an HIV drug decided to settle, before the jury could decide their claims.
One of those sets of plaintiffs - a class of direct purchaser drug retailers a...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In